Al's Comment:

 This trial for recurrent malignant glioma is now available in 3 major centers in Texas.  It is a new way to target radiation to the tumor. Early trial results reported promising extension of survival for recurrent glioblastoma.


Posted on: 12/10/2020

PLUS THERAPEUTICS EXPANDS RESPECT CLINICAL TRIAL TO MD ANDERSON CANCER CENTER

 


Click HERE to return to brain tumor news headlines.